Henri-Jacques Delecluse

  • 6981 Citations
  • 47 h-Index
1990 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Henri-Jacques Delecluse is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles
Human Herpesvirus 4 Medicine & Life Sciences
Human herpesvirus 4 Agriculture & Biology
B-Lymphocytes Medicine & Life Sciences
Epstein-Barr Virus Infections Medicine & Life Sciences
Viruses Medicine & Life Sciences
Lymphoma Medicine & Life Sciences
Viral Genes Medicine & Life Sciences
Burkitt Lymphoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1990 2019

3 Citations (Scopus)

Antibodies conjugated with viral antigens elicit a cytotoxic T cell response against primary CLL ex vivo

Schneidt, V., Ilecka, M., Dreger, P., van Zyl, D. G., Fink, S., Mautner, J. & Delecluse, H-J., Jan 1 2019, In : Leukemia. 33, 1, p. 88-98 11 p.

Research output: Contribution to journalArticle

Viral Antigens
B-Cell Chronic Lymphocytic Leukemia
Viruses
T-Lymphocytes
Antibodies

Correction: Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency (Oncotarget (2017) 8 (7248–7264) DOI: 10.18632/oncotarget.14540)

Dheekollu, J., Malecka, K., Wiedmer, A., Delecluse, H-J., Chiang, A. K. S., Altieri, D. C., Messick, T. E. & Lieberman, P. M., Jul 1 2019, In : Oncotarget. 10, 43, p. 4505-4506 2 p.

Research output: Contribution to journalComment/debate

Virus Latency
Human Herpesvirus 4
Actins
Carcinoma
1 Citation (Scopus)

Progress in EBV vaccines

Van Zyl, D. G., Mautner, J. & Delecluse, H-J., Jan 1 2019, In : Frontiers in Oncology. 9, FEB, 104.

Research output: Contribution to journalReview article

Open Access
Human Herpesvirus 4
Vaccines
Epstein-Barr Virus Infections
Vaccination
Phase II Clinical Trials

Antigen-Armed antibodies against B-cell malignancies

Ilecka, M., Van Zyl, D. G. & Delecluse, H-J., Nov 1 2018, In : Oncotarget. 9, 86, p. 35601-35602 2 p.

Research output: Contribution to journalEditorial

Immunotherapy
Lymphoma
Leukemia
B-Lymphocytes
Antigens
3 Citations (Scopus)

Epstein–Barr virus strain heterogeneity impairs human T-cell immunity

Cirac, A., Stützle, S., Dieckmeyer, M., Adhikary, D., Moosmann, A., Körber, N., Bauer, T., Witter, K., Delecluse, H-J., Behrends, U. & Mautner, J., Apr 1 2018, In : Cancer Immunology, Immunotherapy. 67, 4, p. 663-674 12 p.

Research output: Contribution to journalArticle

Immunity
Viruses
T-Lymphocytes
Epitopes
Oncogenic Viruses